financetom
Business
financetom
/
Business
/
Rakovina Therapeutics To Unveil Preclinical Data at Cancer Research Forum
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rakovina Therapeutics To Unveil Preclinical Data at Cancer Research Forum
Mar 25, 2025 1:42 PM

04:21 PM EDT, 03/25/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) after trade Tuesday said two of its abstracts have been accepted for presentation at the upcoming 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 in Chicago.

According to a statement the AACR Annual Meeting is widely considered the most prestigious global forum for cancer research. It said Rakovina's acceptance to present, highlights "growing recognition for its pioneering work at the intersection of AI technology and precision cancer therapy".

Rakovina shares closed down $0.015 to $0.115 on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corteva Q4 Non-GAAP Operating Earnings, Net Sales Rise; Shares Fall After Hours
Corteva Q4 Non-GAAP Operating Earnings, Net Sales Rise; Shares Fall After Hours
Feb 5, 2025
05:03 PM EST, 02/05/2025 (MT Newswires) -- Corteva ( CTVA ) reported Q4 non-GAAP operating earnings Wednesday of $0.32 per diluted share, up from $0.15 a year earlier. Analysts polled by FactSet expected non-GAAP EPS of $0.31. Net sales in the three months ended Dec. 31 rose to $3.98 billion from $3.71 billion a year earlier. Analysts surveyed by FactSet...
Ensign Group Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued
Ensign Group Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued
Feb 5, 2025
05:01 PM EST, 02/05/2025 (MT Newswires) -- Ensign Group ( ENSG ) reported Q4 adjusted earnings late Wednesday of $1.49 per diluted share, up from $1.28 a year earlier. Analysts polled by FactSet expected $1.48. Revenue for the quarter ended Dec. 31 rose to $1.13 billion from $980.4 million a year earlier. Analysts surveyed by FactSet expected $1.13 billion. For...
First Industrial Realty Trust's Q4 FFO, Revenue Rise
First Industrial Realty Trust's Q4 FFO, Revenue Rise
Feb 5, 2025
05:02 PM EST, 02/05/2025 (MT Newswires) -- First Industrial Realty Trust ( FR ) reported Q4 funds from operations Wednesday of $0.71 per diluted share, up from $0.63 a year earlier. Analysts polled by FactSet expected $0.69. Revenue for the quarter ended Dec. 31 was $175.6 million compared with $157.3 million a year earlier. Analysts surveyed by FactSet expected $170.3...
Markel Q4 Earnings, Operating Revenue Decrease
Markel Q4 Earnings, Operating Revenue Decrease
Feb 5, 2025
05:03 PM EST, 02/05/2025 (MT Newswires) -- Markel ( MKL ) reported Q4 earnings Wednesday of $38.74 per diluted share, down from $56.48 a year earlier. Operating revenue for the quarter ended Dec. 31 was $3.84 billion, down from $4.64 billion a year earlier. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved